Cresp®, a product by Dr. Reddy's, a darbapoetin alpha biosimilar agent which helps in treatment of renal anemia in pre-dialysis patients.
Change for better...change to
Abbreviations ▼
CKD: Chronic kidney disease; EPO: Erythropoietin; ESA: Erythropoiesis-stimulating agent; Hb: Hemoglobin; HD: Hemodialysis; HRQoL: Health-related quality of life; IV: Intravenous; KDIGO: Kidney Disease Improving Global Outcomes; rHuEPO: Recombinant human erythropoietin; PK: Pharmacokinetics; PD: Pharmacodynamics; SC: Subcutaneous; QW: Once weekly; QTIW: Three times per week
References ▼
1. Mehta KS, Sinha SD, Vamsi B, et al. Darbepoetin alfa versus erythropoietin alfa for treatment of renal anemia in patients with chronic kidney disease at the pre-dialysis stage: A randomized non-inferiority trial. J Assoc Physicians India. 2019;67(1):62–66. 2. Palmer SC, Saglimbene V, Craig JC, et al. Darbepoetin for the anaemia of chronic kidney disease. Cochrane Database Syst Rev. 2014;(3):CD009297. 3. Alkatheri A, Albekairy A, Al-Rajhi Y, et al. Comparison of the effectiveness of equal doses of short and long-acting erythrocyte stimulating agents for managing anemia in chronic kidney disease adult patients. Int J Med Res Health Sci. 2016;5(12):335–342. 4. Cresp. Available at: https://www.cresp.in/development.html. Accessed on: 30 October 2023.
Cresp®(Biosimilar of darbepoetin alpha), a product by Dr. Reddy's is an erythropoiesis-stimulating agent which helps in treatment of renal anemia in pre-dialysis patients
